StockNews.com initiated coverage on shares of Brainstorm Cell Therapeutics (NASDAQ:BCLI – Free Report) in a research note released on Friday. The brokerage issued a hold rating on the biotechnology company’s stock. Brainstorm Cell Therapeutics Stock Performance Shares of NASDAQ BCLI opened at $0.54 on Friday. The firm has a market cap of $37.65 million, a […]
StockNews.com initiated coverage on shares of Brainstorm Cell Therapeutics (NASDAQ:BCLI – Free Report) in a research report sent to investors on Friday. The firm issued a hold rating on the biotechnology company’s stock. Brainstorm Cell Therapeutics Trading Down 7.0 % Shares of NASDAQ BCLI opened at $0.54 on Friday. The firm has a 50 day […]
StockNews.com assumed coverage on shares of Brainstorm Cell Therapeutics (NASDAQ:BCLI – Free Report) in a research note published on Friday. The firm issued a hold rating on the biotechnology company’s stock. Brainstorm Cell Therapeutics Stock Down 7.0 % BCLI stock opened at $0.54 on Friday. Brainstorm Cell Therapeutics has a 52-week low of $0.13 and […]
The data will be presented at the Annual ALS Drug Development Summit, which is focused on identifying transformative ALS targets, seeking translational biomarkers and propelling more clinical.